Cargando…
Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv
BACKGROUND: Consistent data on clinical features, treatment modalities and long‐term survival in patients with hepatocellular carcinoma (HCC) using nationwide quality registers are lacking. This study aimed to describe treatment patterns and survival outcomes in patients diagnosed with HCC using a n...
Autores principales: | Henriksson, M., Björnsson, B., Sternby Eilard, M., Lindell, G., Strömberg, C., Hemmingsson, O., Isaksson, B., Rizell, M., Sandström, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996573/ https://www.ncbi.nlm.nih.gov/pubmed/32011814 http://dx.doi.org/10.1002/bjs5.50226 |
Ejemplares similares
-
Validation of the Swedish Trauma Registry (SweTrau)
por: Holmberg, Lina, et al.
Publicado: (2023) -
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
por: Rizell, Magnus, et al.
Publicado: (2019) -
Combination of biomarkers for the detection of hepatocellular carcinoma
por: Sternby Eilard, Malin, et al.
Publicado: (2020) -
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
por: Eilard, Malin Sternby, et al.
Publicado: (2019) -
Targeting population groups with heavier burden of hepatocellular carcinoma incidence: A nationwide descriptive epidemiological study in Sweden
por: Vaz, Juan, et al.
Publicado: (2022)